Loading...
Market
Story
EU and US Procure H5N1 Bird-Flu Vaccines Amid Pandemic Concerns
Jul 8, 2024, 11:14 AM
Finland and fourteen other EU countries have signed up to procure bird-flu vaccines, with the American government also purchasing them in anticipation of a potential pandemic. This move comes as a strain of H5N1 bird flu currently circulating has infected hundreds of mammals, which is usually rare for the virus. Research aims to understand how avian influenza circulating in nature might develop mutations that could allow it to spread between mammals.
View original story
Similar markets
Pfizer • 25%
Moderna • 25%
Johnson & Johnson • 25%
Other • 25%
Moderna • 25%
Sinergium Biotech • 25%
Pfizer • 25%
Other • 25%
GSK • 33%
Sanofi • 33%
Seqirus • 33%
GSK • 25%
Sanofi • 25%
CSL • 25%
None by deadline • 25%
Pfizer • 25%
Merck • 25%
Zoetis • 25%
Other • 25%
Vaccine approved and in use • 25%
Vaccine in clinical trials • 25%
Vaccine in development but not in trials • 25%
No vaccine development • 25%
Moderna • 25%
Sinergium Biotech • 25%
Pfizer • 25%
Other • 25%
Company A • 25%
Company B • 25%
Company C • 25%
Other • 25%
Pfizer • 25%
Johnson & Johnson • 25%
AstraZeneca • 25%
Other • 25%
